Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic... (Publications)
BACKGROUND: A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered acr
Characterizing the biochemical response to <em>Schistosoma mansoni</em> infection and treatment with praziquantel in preschool and school aged... (Publications)
Schistosomiasis is a widespread chronic neglected tropical disease prevalent mostly in children in under-resourced rural areas. Its pathological effects have been clinically characterized, yet the mol
Metal hypersensitivity in patients with orthopaedic implant complications: a retrospective clinical study (Publications)
BACKGROUND: Hypersensitivity to metals as a cause of implant-related complications has been a subject of controversy. Projections indicate an increase in the frequency of joint replacements of between
Measuring subjective flood resilience in suburban Dakar: a before–after evaluation of the “Live with water” project (Publications)
In the last decade, sub-Saharan African countries have taken various measures to plan for and adapt to floods in order to reduce exposure and its impacts on human health, livelihoods, and infrastructu
Challenges and prospects for integrating the assessment of health impacts in the licensing process of large capital project in Brazil (Publications)
Brazil was one of the first countries in Latin America to institutionalize a National Environmental Policy in 1981, including the environmental impact assessment (EIA) process of economic activities w
Data integration for the assessment of population exposure to ambient air pollution for global burden of disease assessment (Publications)
Air pollution is a leading global disease risk factor. Tracking progress (e.g. for Sustainable Development Goals) requires accurate, spatially resolved, routinely updated exposure estimates. A Bayesia
UCT943, a next generation <em>Plasmodium falciparum</em> PI4K inhibitor preclinical candidate for the treatment of malaria (Publications)
The 2-aminopyridine MMV048 was the first drug candidate inhibiting Plasmodium phosphatidylinositol 4-kinase (PI4K), a novel drug target for malaria, to enter clinical development. In an effort to iden
